Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on mPGES 1 Inhibitor. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step synthesis of FR20 inhibitor avoids toxic reagents. High atom economy and scalable process for pharmaceutical intermediates.